Phage display screening of therapeutic peptide for cancer targeting and therapy

PE Saw, EW Song - Protein & cell, 2019 - academic.oup.com
Recently, phage display technology has been announced as the recipient of Nobel Prize in
Chemistry 2018. Phage display technique allows high affinity target-binding peptides to be …

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

J Mendelsohn, J Baselga - Journal of clinical oncology, 2003 - ascopubs.org
The epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor of the ErbB family
that is abnormally activated in many epithelial tumors. Receptor activation leads to …

ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck …

M Gebre-Medhin, E Brun, P Engström… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE We performed an open-label randomized controlled phase III study comparing
treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus …

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

KK Ang, Q Zhang, DI Rosenthal… - Journal of clinical …, 2014 - ascopubs.org
Purpose Combining cisplatin or cetuximab with radiation improves overall survival (OS) of
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …

[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a multinational, randomized study to compare radiotherapy
alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal …

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma

KK Ang, BA Berkey, X Tu, HZ Zhang, R Katz… - Cancer research, 2002 - AACR
A correlative study was performed to address the impact of epidermal growth factor receptor
(EGFR) overexpression on survival and pattern of failure in patients with advanced head …

The EGF receptor family as targets for cancer therapy

J Mendelsohn, J Baselga - Oncogene, 2000 - nature.com
Human carcinomas frequently express high levels of receptors in the EGF receptor family,
and overexpression of at least two of these receptors, the EGF receptor (EGFr) and closely …

Exploring the role of cancer stem cells in radioresistance

M Baumann, M Krause, R Hill - Nature Reviews Cancer, 2008 - nature.com
Radiobiological research over the past decades has provided evidence that cancer stem
cell content and the intrinsic radiosensitivity of cancer stem cells varies between tumours …

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor

F Ciardiello, G Tortora - Clinical Cancer Research, 2001 - AACR
The epidermal growth factor receptor (EGFR) autocrine pathway contributes to a number of
processes important to cancer development and progression, including cell proliferation …

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

N Prenzel, OM Fischer, S Streit, S Hart… - Endocrine-related …, 2001 - erc.bioscientifica.com
Homeostasis of multicellular organisms is critically dependent on the correct interpretation of
the plethora of signals which cells are exposed to during their lifespan. Various soluble …